A new anti-cancer immunological approach devised and experimented for years by Dr. Fernando Ferretti, is presented. Cobra Venom Factor is incubated with filtered Naja Naja Kaouthia serum and the mix obtained is injected subcutaneously. Due to the close functional similarity between Cobra Venom Factor and human Complement C3b, as well as the likely similarity between their inhibitors, the induced antibodies are hypothesized to cross react with Complement inhibitors and help restore the immune anti-cancer mechanisms. 1.2. Methods and Results of mix component analysis: The electrophoretic analysis of Cobra Venom Factor, Naja serum and the therapeutic mix was performed and it showed that complex interactions occur between Cobra Venom Factor and serum, leading to the formation of new molecules in the mix. 1.3. Case report: We describe 8 cases of cancer treated with the present approach. Following immunogen injections, the patients generally experienced a transient increase in pain in the regions of primary and secondary cancer lesions, then the pain reduced and they felt better that before the injection. Overall, the effects observed ranged from complete healing to an increase of life duration beyond medical expectancy, together with a state of general well-being, decrease or disappearance of pain, new energy, a new positive sense of life. 1.4. Discussion: This therapy is aimed at balancing the various molecular components of the immune system, so as to restore its natural antitumor activity. A specific link is suggested between mix immunogens and the malignancy process

Federica Facchin, Margherita Ciano, Silvia Canaider, Fernando Ferretti, Anna Ferretti, Gianluigi Veronesi, et al. (2014). Treating Cancer with Snake Venom and Serum: Case Series. ALTERNATIVE & INTEGRATIVE MEDICINE, 3(167), 1-10 [10.4172/2327-5162.1000167].

Treating Cancer with Snake Venom and Serum: Case Series

FACCHIN, FEDERICA;CANAIDER, SILVIA;IOTTI, STEFANO;LENZI, PIERLUIGI
2014

Abstract

A new anti-cancer immunological approach devised and experimented for years by Dr. Fernando Ferretti, is presented. Cobra Venom Factor is incubated with filtered Naja Naja Kaouthia serum and the mix obtained is injected subcutaneously. Due to the close functional similarity between Cobra Venom Factor and human Complement C3b, as well as the likely similarity between their inhibitors, the induced antibodies are hypothesized to cross react with Complement inhibitors and help restore the immune anti-cancer mechanisms. 1.2. Methods and Results of mix component analysis: The electrophoretic analysis of Cobra Venom Factor, Naja serum and the therapeutic mix was performed and it showed that complex interactions occur between Cobra Venom Factor and serum, leading to the formation of new molecules in the mix. 1.3. Case report: We describe 8 cases of cancer treated with the present approach. Following immunogen injections, the patients generally experienced a transient increase in pain in the regions of primary and secondary cancer lesions, then the pain reduced and they felt better that before the injection. Overall, the effects observed ranged from complete healing to an increase of life duration beyond medical expectancy, together with a state of general well-being, decrease or disappearance of pain, new energy, a new positive sense of life. 1.4. Discussion: This therapy is aimed at balancing the various molecular components of the immune system, so as to restore its natural antitumor activity. A specific link is suggested between mix immunogens and the malignancy process
2014
Federica Facchin, Margherita Ciano, Silvia Canaider, Fernando Ferretti, Anna Ferretti, Gianluigi Veronesi, et al. (2014). Treating Cancer with Snake Venom and Serum: Case Series. ALTERNATIVE & INTEGRATIVE MEDICINE, 3(167), 1-10 [10.4172/2327-5162.1000167].
Federica Facchin; Margherita Ciano; Silvia Canaider; Fernando Ferretti; Anna Ferretti; Gianluigi Veronesi; Stefano Iotti; Pierluigi Lenzi
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/372523
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact